Pixilab
Home › Companies › SEC Form D - Pharmaceuticals › Novellus, Inc.

Novellus, Inc.

SEC Form D private-offering issuer in Pharmaceuticals

Operating in sec form d - pharmaceuticals based in CAMBRIDGE, MASSACHUSETTS, Novellus, Inc. was founded in 2014.

Profile

Private US issuer recorded in the SEC Form D structured dataset for 2014Q3. Industry: Pharmaceuticals. Revenue range: Decline to Disclose. Offering amount: 2500000.

Within the sec form d - pharmaceuticals space, the company focuses on its core offering rather than a broad product line.

The business is associated with CAMBRIDGE, MASSACHUSETTS.

Its current recorded stage is Regulation D.

Recorded headcount: 1-10 employees.

It has disclosed roughly $2.5M in funding.

SectorSEC Form D - Pharmaceuticals
HeadquartersCAMBRIDGE, MASSACHUSETTS
CountryUnited States
Founded2014
Employees1-10
StageRegulation D
Total funding$2,500,000

Website: novellus-inc.com

Browse related

More SEC Form D - Pharmaceuticals companies Companies in United States Companies founded in 2014
Emails and contact routes are reserved for registered members.
Create a free account